Follow the Vimian AB (publ) share price and the full insider trade history of the company, a listed equity based in Finland. Shares are listed on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, Vimian AB (publ) has logged 0 public disclosures. Market capitalisation: €17.7bn. All data is openly available.
Analysts rate Vimian AB (publ) Buy (bullish), based on 6 analysts. Average price target: SEK 35.72.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
Vimian AB (publ) is a publicly traded company on the Stockholm Stock Exchange, specializing in the health and pharmaceutical sector. It focuses on developing innovative solutions to enhance veterinary healthcare.